Lineage transitions are a central feature of prostate development, tumorigenesis and treatment resistance. We discovered that inhibition of mitochondrial pyruvate uptake results in large-scale chromatin remodelling of key lineage-specific genes, antagonizes luminal lineage identity, and alters response to antiandrogen therapy in prostate cancer.
References
Choi, N. et al. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell. 21, 253–265 (2012). This paper reports on prostate epithelial lineage hierarchy.
Kwon, O. et al. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell of origin. Proc. Natl Acad. Sci. USA 5, 592–600 (2013). This paper reports on the role of inflammation in promoting differentiation and cancer initiation in the prostate.
Stoyanova, T. et al. Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells. Proc. Natl Acad. Sci. USA 110, 20111–20116 (2013). This paper reports on two histological phenotypes of cancer arising from a common target cell.
Dai, Z. et al. The evolving metabolic landscape of chromatin biology and epigenetics. Nat. Rev. Genet. 21, 737–753 (2020). A review article on the interplay between metabolism and epigenetics.
Beltran, H. et al. The role of lineage plasticity in prostate cancer therapy resistance. Clin. Can. Res. 25, 6916–6924 (2019). A review article on lineage plasticity as a mechanism of treatment resistance.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Giafaglione, J. M. et al. Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment. Nat. Cell Biol. https://doi.org/10.1038/s41556-023-01274-x (2023).
Rights and permissions
About this article
Cite this article
Pyruvate metabolism regulates prostate cell fate and response to cancer therapy. Nat Cell Biol 25, 1734–1735 (2023). https://doi.org/10.1038/s41556-023-01290-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41556-023-01290-x
- Springer Nature Limited